SBL VACCIN AB has a total of 65 patent applications. Its first patent ever was published in 1994. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are AVANT IMMUNOTHERAPEUTICS INC, SMITHKLINE BEECHAM BIOLOGICALS SA and NORTHERN ANTIBIOTICS OY.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 9 | |
#2 | Australia | 8 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Sweden | 6 | |
#5 | United States | 5 | |
#6 | Canada | 4 | |
#7 | China | 4 | |
#8 | Norway | 3 | |
#9 | Israel | 2 | |
#10 | Mexico | 2 | |
#11 | New Zealand | 2 | |
#12 | Poland | 2 | |
#13 | Brazil | 1 | |
#14 | Czechia | 1 | |
#15 | Estonia | 1 | |
#16 | United Kingdom | 1 | |
#17 | Croatia | 1 | |
#18 | Hungary | 1 | |
#19 | Indonesia | 1 | |
#20 | Iceland | 1 | |
#21 | African Intellectual Property Organization | 1 | |
#22 | Yugoslavia (Serbia and Montenegro) | 1 | |
#23 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Peptides | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Carlin Nils | 36 |
#2 | Bjare Ulf | 19 |
#3 | Askeloef Per | 17 |
#4 | Lebens Michael | 9 |
#5 | Askelof Per | 7 |
#6 | Nilsson Bo | 7 |
#7 | Paulsson Agneta | 6 |
#8 | Simmaco Maurizio | 6 |
#9 | Barra Donnatella | 5 |
#10 | Lebens Michael R | 4 |
Publication | Filing date | Title |
---|---|---|
WO2009004002A1 | Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli | |
WO2007089205A1 | Colonization factor (cf) antigens of enterotoxigenic escherichia coli in recombinant bacteria | |
GB0325494D0 | Expression system | |
CA2372250A1 | Fimbrial proteins | |
AU3088900A | Oral vaccine against diarrhea | |
PL344483A1 | Method of producing thy a¯strains of vibrio cholerae, such strains and their use | |
AU5501498A | Antimicrobially active polypeptides | |
WO9804588A1 | Lymphocyte stimulating factor from trypanosoma | |
AU1740197A | Vaccine against hantavirus | |
US5935838A | Method of cultivating bacteria proteins that are expressed in a temperature regulated manner |